Viewing Study NCT03232203


Ignite Creation Date: 2025-12-24 @ 7:19 PM
Ignite Modification Date: 2026-02-04 @ 2:39 AM
Study NCT ID: NCT03232203
Status: COMPLETED
Last Update Posted: 2023-11-14
First Post: 2017-07-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluating the Effectiveness of STRIMVELIS Risk Minimization Measures (RMMs)
Sponsor:
Organization:

Study Design

Study Type: OBSERVATIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: True
Target Duration: 2 Years
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count:
Enrollment Type:
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
Time Perspective List:
Who Masked List: